Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04003454 · ClinicalTrials.gov registry record · NA
The DETECT HCV Screening Trial
A NA study of Hepatitis C, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 147,533
- Enrollment target
- 3
- Study locations
NCT04003454 is a NA study of Hepatitis C that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 147,533 participants, above the 498-participant average among 106 other Hepatitis C trials with a reported enrollment target (29525% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT04003454, a NA study of Hepatitis C, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 147,533 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators propose to compare the effectiveness of nontargeted rapid opt-out hepatitis C (HCV) screening versus targeted rapid opt-out HCV screening using recommended risk characteristics in multiple urban emergency departments (EDs) across the United States (Aim 1 - "Screening Trial").
Conditions Studied
Interventions
- OTHER HCV Screening
Study Locations (3)
Colorado
- Denver Health Medical Center - Denver
Maryland
- Johns Hopkins University - Baltimore
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147,533 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04003454
The ClinicalTrials.gov registry entry for NCT04003454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147,533 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 498-participant average among 106 other Hepatitis C trials with a reported enrollment target (29525% higher). The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which HCV Screening is the first listed.
NCT04003454 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Maryland, Mississippi.
Frequently Asked Questions
What is clinical trial NCT04003454 about?
NCT04003454 is a clinical study titled "The DETECT HCV Screening Trial". The investigators propose to compare the effectiveness of nontargeted rapid opt-out hepatitis C (HCV) screening versus targeted rapid opt-out HCV screening using recommended risk characteristics in multiple urban emergency departments (EDs) across the United States (Aim 1 - "Screening Trial").
What is the current status of trial NCT04003454?
This trial is currently completed. It is a NA study. The enrollment target is 147,533 participants. The study started on 2019-11-20. Estimated completion is 2024-01-31.
What conditions does trial NCT04003454 study?
This clinical trial studies the following conditions: Hepatitis C.
What interventions are being tested in trial NCT04003454?
The interventions under investigation include: HCV Screening (OTHER).
Who is sponsoring clinical trial NCT04003454?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04003454 being conducted?
This trial has 3 study locations across Colorado, Maryland, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
HCV Tappt Adherence Study
RECRUITING · NA
-
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
RECRUITING · NA
-
Buprenorphine Integration Research and Community Health
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.